1. Adams, R. J., Cohen, D. W., Gupte, S., Johnson, J. D., Wallick, E. T., Wang, T. and Schwartz, A. (1979). In vitro effects of palmitylcarnitine on cardiac plasma membrane Na, K-ATPase, and sarcoplasmic reticulum Ca2+-ATPase and Ca2+ transport. J. Biol. Chem., 254,12404–12410
2. Allely, M. C. and Brown, C. M. (1988). The effects of POCA and TGDA on the ischaemia-induced increase in a -adrenoceptor density in the rat left ventricle. Br. J. Pharmacol., 95, 705 P
3. Allen, D. G. and Orchard, C. H. (1987). Myocardial contractile function during ischemia and hypoxia. Circ. Res., 60, 153–168
4. Bachmann, E., Weber, E. and Zbinden, G. (1983). Biochemical aspects of cardiotoxic effects of a novel type hypoglycemic agent in rats. J. Mot. Cell. Cardiol., 15 (Suppl. 1), 67
5. Beneking, M., Oellerich, M., Binder, L., Choitz, G.-F. and Haeckel, R. (1990). Inhibition of mitochondrial carnitine acylcarnitine translocase by hypoglycaemia-inducing substances. J. Clin. Chem. Clin. Biochem., 28, 323–327